« Return to News | Ethics/Regulatory

BU professor fabricates data in two published experiments

Wednesday, August 10, 2011 11:43 AM

A cancer researcher and assistant professor at the Boston University School of Medicine Cancer Research Center fabricated data in two papers published in scientific journals, federal authorities announced, according to a report by the Boston Globe.

Sheng Wang, an assistant professor whose research involved molecular biology approaches to understanding cancer, no longer works at BU.  Wang has agreed to retract the two papers and will not be eligible for or involved in federally funded research for two years, according to the finding of research misconduct issued by the Office of Research Integrity of the US Department of Health and Human Services.

The federal authorities found that Wang engaged in research misconduct in projects supported by two federal grants from the National Cancer Institute. According to the federal finding, Wang fabricated experiments used in six out of seven figures in one paper and six out of eight figures in the other. He is listed as the senior author on both papers, which were published in 2009 and explored the role of a gene that suppresses tumor growth.

The sanctions described in the misconduct findings include Wang’s agreement to exclude himself from receiving funds or working for any US government agency for two years. He is also barred from serving on advisory or peer review committees, or as a consultant for the government’s Public Health Service.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.